期刊文献+

DC-CIK共培养在AL化疗后免疫治疗中的应用及其对NKG2D表达的影响 被引量:3

Effect of dentritic cells-cytokine-induced killer cells coculture therapy on NKG2D after chemotherapy of acute leukemia
下载PDF
导出
摘要 目的观察树突状细胞(DC)—细胞因子诱导的杀伤细胞(CIK)共培养用于急性白血病(AL)化疗后免疫治疗的疗效,及其对自然杀伤(NK)细胞表面活化受体NKG2D表达的影响。方法 31例AL患者经诱导治疗骨髓达完全缓解后,给予DC-CIK共培养治疗。治疗前后检测外周血中T细胞亚群表达、血清IL-2、IL-12、TNF-α、IFN-γ水平及外周血中NKG2D的表达。结果所有患者治疗结束后骨髓均处于完全缓解状态;DC-CIK共培养治疗后,CD3+、CD3+CD8+、CD3+CD5+6/CD1+6高于治疗前(P均<0.05);血清IL-2、IL-12、TNF-α、IFN-γ水平高于治疗前(P均<0.05);外周血单个核细胞中NKG2D阳性表达率为25.41%±8.47%,高于治疗前的8.07%±2.02%(P<0.05)。结论 DC-CIK共培养用于AL化疗后的免疫治疗效果较好,能更有效地清除微小残留病灶,提高外周血中NKG2D的表达,纠正AL细胞对自体NK细胞的免疫编辑作用。 Objective To investigate the effect of dentritic cells-cytokine induced killer ceils (DC-CIK) cocultrue ther- apy on nature killer cell group 2, member D (NKG2D). Methods DC-CIK cocultrue therapy was adopted in 31 acute leu- kemia (AL) patients when they were in complete remission after inductive treatment. The levels oft cell subsets(including CD3+ ,CD3+CD8+ , CD3+CD56+/CD16+), IL-2,IL-12,TNF,IFN-γand the expression of NKG2D were observed before and after the treatment. Results All patients were in complete remmission after threatment. The expression of CD3+, CD3+CD8+ , CD3+ CD56+/CD16+ were higher than that of treatment before. The positive rate of NKG2D in peripheral blood was 25.41% ± 8.47% , which was higher than that of treatment before ( that was 8.07% ± 2.02% ). Conclusion DC-CIK eocultrue treatment is effective in immunotherapy after the chemotherapy of AL, by which the expression of NKG2D enhanced, immu- nity edition of NK cells corrected.
出处 《山东医药》 CAS 2013年第2期1-3,共3页 Shandong Medical Journal
基金 天津市卫生局科技基金资助项目(2011ky07)
关键词 急性白血病 树突状细胞 细胞因子诱导的杀伤细胞 自然杀伤细胞 acute leukemia dentritic cells cytokine-induced killer cells natural killer cell
  • 相关文献

参考文献15

  • 1梅家转,周健,郭坤元.自然杀伤细胞与肿瘤细胞之间的免疫编辑[J].中国肿瘤生物治疗杂志,2008,15(1):86-89. 被引量:18
  • 2Reiman JM,Kmieciak M,Manjili MH. Tumor immunoediting and immunosculpting pathways to cancer progression[J].Seminars in Cancer Biology,2007,(04):275-287.doi:10.1016/j.semcancer.2007.06.009.
  • 3张之南;沈悌.血液病诊断及疗效标准[M]北京:科学出版社,2007103-105.
  • 4Cooper MA,Fehniger TA,Caligiuri MA. The biology of human natural Killer-cell subsets[J].Trends in Immunology,2001,(11):633-640.doi:10.1016/S1471-4906(01)02060-9.
  • 5Richards JO,Chang X,Blaser BW. Tumor growth impedes natural-killer-cell maturation in the bone marrow[J].Blood,2006,(01):246-252.
  • 6Colucci F,Caligiuri MA,Di Santo JP. What does it take to make a natural killer[J].Nature Reviews Immunology,2003,(05):413-425.
  • 7Fauriat C,Just-Landi S,Mallet F. Deficient expression of NCR in NK cells from acute myeloid leukemia:evolution during leukemia treatment and impact of leukemia cells in NCR dull phenotype induction[J].Blood,2007,(01):323-330.
  • 8Fauriat C,Moretta A,Olive D. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients[J].Blood,2005,(06):2186-2188.
  • 9Leemhuis T,Wells S,Scheffold C. A phase Ⅰ trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma[J].Biod Blood Marrow Transplant,2005,(03):181-187.doi:10.1016/j.bbmt.2004.11.019.
  • 10Linn YC,Hui KM. Cytokine-induced killer cells:NK-like cells with cytotolytic specificity against leukemia[J].Leukemia and Lymphoma,2003,(09):1457-1462.

二级参考文献32

共引文献17

同被引文献34

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部